A Phase 1 Trial of SRA737 in Subjects With Advanced Cancer

Condition:   Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Intervention:   Drug: SRA737
Sponsor:   Sierra Oncology, Inc.
Recruiting - verified April 2017

http://ift.tt/2qI3edW


http://ift.tt/2qI9B0Q